Transcatheter ablation of septal hypertrophy: A promising alternative to surgery in hypertrophic obstructive cardiomyopathy

Israel Medical Association Journal

Volumn 4, Issue 2, 2002, Pages 114-116

  Keren, Andre ^a   Banai, Shmuel ^a  

^a BIKUR CHOLIM HOSPITAL   (Israel)

Author keywords

Ablation; Alcohol; Catheterization; Hypertrophic cardiomyopathy; Myocardial disease

Indexed keywords

AORTA PRESSURE; ARTIFICIAL HEART PACEMAKER; CATHETER ABLATION; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLETE HEART BLOCK; DISEASE SEVERITY; EDITORIAL; FOLLOW UP; HEART CATHETERIZATION; HEART HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART LEFT VENTRICLE PRESSURE; HEART SURGERY; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MITRAL VALVE REGURGITATION; MYOTOMY; OUTCOMES RESEARCH; TECHNIQUE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; HEMODYNAMIC PROCESSES; HUMANS; VENTRICULAR OUTFLOW OBSTRUCTION; VENTRICULAR REMODELING;

EID: 0036191866     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (25)

1. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
2. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy
3. Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial
4. Pacing in hypertrophic obstructive cardiomyopathy: A randomized crossover study. PIC Study Group
5. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: A randomized double blind, crossover study (M-Pathy)
6. Transcoronary chemical ablation of ventricular tachycardia
7. Induction of subaortic septal ischemia to reduce obstructive in hypertrophic obstructive cardiomyopathy: Studies to develop a new catheter-based concept of treatment
8. Non-surgical myocardial reduction in hypertrophic obstructive cardiomyopathy
9. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-months follow-up in 25 patients
10. Echocardiographic-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy
11. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH)
12. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy
13. Transcoronary ablation of septal hypertrophy (TASH): A new treatment option for hypertrophic obstructive cardiomyopathy
14. Percutaneous transluminal septal myocardial ablation; A new treatment for hypertrophic obstructive cardiomyopathy
15. Catheter interventional therapy for hypertrophic obstructive cardiomyopathy: First two years analysis of the national registry of the German Cardiac Society
16. Current status of alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy
17. Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients
18. Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy
19. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Results with respect to intraprocedural myocardial contrast echocardiography
20. Catheter interventional septal ablation for hypertrophic obstructive cardiomyopathy: An analysis of the follow-up data from the registry of the German Society of Cardiology
21. Symptomatic and hemodynamic effects of right bundle branch block induced by transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy
22. Role of transcoronary ablation of septal hypertrophy for relief of syncope in hypertrophic obstructive cardiomyopathy
23. Normalization of an abnormal blood pressure response after septal ablation for hypertrophic obstructive cardiomyopathy
24. Hypertrophic obstructive cardiomyopathy (HOCM): Surgical management
25. Long term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy